Tiziana Life Sciences Stock News

NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of mono

NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes

Zak's Small Cap Research has provided its feedback from a ‘key opinion leader virtual event' hosted by Tiziana Life Sciences Ltd. The set-piece was organized after the publication of encouraging dat

Monday, March 14th @ 11 am ET, registration details below Monday, March 14th @ 11 am ET, registration details below

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC ) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI ) gained 102.4% to close at $3.42 after the company announced a binding letter of intent to acquire Deroose Planta NV. Enservco Corporation (NYSE: ENSV ) shares jumped 43.1% to close at $4.32 after dropping 28% on Wednesday. Hoth Therapeutics, Inc. (NASDAQ: HOTH ) gained 38.8% to close at $0.7968 following circulation of an FDA AccessData.gov listing which showed the company''s c-KIT-targeting candidate received orphan-drug designation. AquaBounty Technologies, Inc. (NASDAQ: AQB ) surged 37.8% to close at $1.93 after the company reported FY21 EPS results were higher year over year. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX ) jumped 33.4% to close at $0.50. Almaden Minerals Ltd. (NYSE: AAU ) gained 32.9% to settle at $0.4480. Ebix, Inc. (NASDAQ: EBIX ) jumped 31.4% to settle at $41.90 on Thursday. The company recently posted upbeat quarterly sales.

Tiziana Life Sciences Ltd (NASDAQ: TLSA ) has reported clinical data in a patient with Secondary Progressive Multiple Sclerosis (SPMS) following six months of treatment with intranasally administered foralumab. In addition to being well-tolerated, both biological and clinical improvements were seen in the patient using Tiziana''s immunotherapy technology, which overcame the challenge … Full story available on Benzinga.com

NEW YORK , March 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TLSA, INDO, USWS, KALA, and NINE. … Full story available on Benzinga.com

Tiziana Life Sciences ((TLSA)) reported positive data from a patient with Secondary Progressive Multiple Sclerosis ((SPMS)) treated for six months with intranasally…

Penny stocks are on the move today with some of the top companies in the space seeing major movement alongside heavy trading of their shares. The post Top Penny Stocks Today: Why PT, TLSA, AGRI and HT

NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.’s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY) (formerly AccuStem Sciences Ltd.), today annou

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel rou

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel route

- Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b Clinical Study

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repur

Tiziana Life Sciences Ltd announced that the US Food and Drugs Administration (FDA) has accepted its request to enroll a second patient onto the ongoing clinical treatment of secondary progressive mul